Evaluation of colchicine therapy in primary biliary cirrhosis.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Gastroenterology

• Publication date

  1988-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0016-5085(88)90300-9PMID 3286360
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Manifestations of nonsuppurative cholangitis in chronic hepatobiliary diseases: morphologic spectrum, clinical correlations and terminology.

  2008cited by this paper
• Low therapeutic value of D-penicillamine in a short-term prospective trial in primary biliary cirrhosis.

  2008cited by this paper
• Accumulation of collagen-containing vacuoles in osteoblasts after administration of colchicine

  2004cited by this paper
• [Primary biliary cirrhosis].

  1989cited by this paper
• A controlled trial of colchicine in primary biliary cirrhosis. Trial design and preliminary report.

  1987cited by this paper
• Randomized trial of chlorambucil for primary biliary cirrhosis.

  1986cited by this paper
• A prospective trial of colchicine for primary biliary cirrhosis.

  1986cited by this paper
• Double blind controlled trial of d-penicillamine in patients with primary biliary cirrhosis.

  1985cited by this paper
• Beneficial Effect of Azathioprine and Prediction of Prognosis in Primary Biliary

  1985cited by this paper
• Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial.

  1985cited by this paper
• Effects of penicillamine on serum immunoglobulins and immune complex-reactive material in primary biliary cirrhosis.

  1985cited by this paper
• Trial of penicillamine in advanced primary biliary cirrhosis.

  1985cited by this paper
• A prospective clinical trial of D‐penicillamine in the treatment of primary biliary cirrhosis

  1985cited by this paper
• The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis.

  1983cited by this paper
• Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment.

  1982cited by this paper
• Bone disease in primary biliary cirrhosis: histologic features and response to 25-hydroxyvitamin D.

  1982cited by this paper
• A prospective trial of D-penicillamine in primary biliary cirrhosis.

  1982cited by this paper
• Possible errors in sampling percutaneous liver biopsies for determination of trace element status: application to patients with primary biliary cirrhosis.

  1981cited by this paper
• The Natural History of Primary Biliary Cirrhosis

  1981cited by this paper
• D-penicillamine treatment improves survival in primary biliary cirrhosis.

  1981cited by this paper
• Azathioprine in primary biliary cirrhosis: a preliminary report of an international trial.

  1980cited by this paper
• Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients.

  1980cited by this paper
• Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients

  1980cited by this paper
• Serum bilirubin: a prognostic factor in primary biliary cirrhosis.

  1979cited by this paper
• State of the art. Primary biliary cirrhosis and the immune system.

  1979cited by this paper
• Treatment of cirrhosis with colchicine. A double-blind randomized trial.

  1979cited by this paper
• Asymptomatic primary biliary cirrhosis. Presentation, histology, and results with D-penicillamine.

  1978cited by this paper
• Crystal-Induced Arthropathies

  1978cited by this paper
• Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)

  1978cited by this paper
• The route of secretion of procollagen. The influence of alphaalpha'-bipyridyl, colchicine and antimycin A on the secretory process in embryonic-chick tendon and cartilage cells.

  1976cited by this paper
• The route of secretion of procollagen. The influence of αα′-bipyridyl, colchicine and antimycin A on the secretory process in embryonic-chick tendon and cartilage cells

  1976cited by this paper
• Influence of colchicine on the synthesis and secretion of proteoglycans and collagen by fetal guinea pig chondrocytes.

  1976cited by this paper
• A prospective controlled trial of azathioprine in primary biliary cirrhosis.

  1976cited by this paper
• The action of colchicine in acute gouty arthritis.

  1975cited by this paper
• Effect of colchicine on collagen, albumin and transferrin synthesis by cirrhotic rat liver slices.

  1975cited by this paper
• Letter: Effect of penicillamine on peripheral-blood lymphocytes in rheumatoid arthritis.

  1975cited by this paper
• Colchicine and the treatment of liver cirrhosis.

  1973cited by this paper
• A defect in the intramolecular and intermolecular cross-linking of collagen caused by penicillamine. II. Functional groups involved in the interaction process.

  1969cited by this paper
• Primary biliary cirrhosis.

  1967cited by this paper
• Lysosomes and Gout

  1966cited by this paper
• Progress in Liver Diseases

  1962cited by this paper
• Efficacy of colchicine prophylaxis in gout. Prevention of recurrent gouty arthritis over a mean period of five years in 208 gouty subjects.

  1961cited by this paper
• Primary billiary cirrhosis (chronic intrahepatic obstructive jaundice).

  1959cited by this paper
• Effect of steroid therapy on the clinical and laboratory features of primary biliary cirrhosis.

  1955cited by this paper

• Colchicine for the primary prevention of cardiovascular events.

  2025cites this paper
• Mechanisms and molecules: What are the treatment targets for primary biliary cholangitis?

  2022cites this paper
• Safety and adverse effect profile of colchicine in renal impairment: a systematic review of randomised trials

  2020cites this paper
• Title Cyclosporin A Treatment in Patients with Primary Biliary Cirrhosis

  2018cites this paper
• Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis.

  2017cites this paper
• Cardiovascular effects and safety of long-term colchicine treatment: Cochrane review and meta-analysis

  2016cites this paper
• Chinese medicine CGA formula ameliorates DMN-induced liver fibrosis in rats via inhibiting MMP2/9, TIMP1/2 and the TGF-β/Smad signaling pathways

  2016cites this paper
• Colchicine for prevention of cardiovascular events.

  2016cites this paper
• 100. Primary Biliary Cirrhosis

  2015cites this paper
• Optimal drug regimens for primary biliary cirrhosis: a systematic review and network meta-analysis

  2015cites this paper
• Ratlarda Pentadekafluorooktanoik Asit ile Oluşturulan Karaciğer Hasarı Üzerine Üzüm Çekirdeği ve Kolşisinin Etkisi

  2014cites this paper
• Old and Novel Therapies for Primary Biliary Cirrhosis

  2014cites this paper
• Immunosuppressive Therapy in Immune-Mediated Liver Disease in the Non-Transplanted Patient

  2013cites this paper
• Anti-fibrotic effect of Cordyceps sinensis polysaccharide: Inhibiting HSC activation, TGF-β1/Smad signalling, MMPs and TIMPs

  2013cites this paper
• Traditional Management of Liver Disorders

  2012cites this paper
• Therapy of Dermatologic, Renal, Cardiovascular, Pulmonary, Gynecologic, Gastro-enterologic, Urologic and Fibromyalgia Manifestations Including Special Considerations at the Time of Surgery

  2011cites this paper
• Current status of novel antifibrotic therapies in patients with chronic liver disease

  2011cites this paper
• Primary Biliary Cirrhosis

  2010cites this paper
• Management of autoimmune and cholestatic liver disorders.

  2009cites this paper
• Primary Biliary Cirrhosis

  2009cites this paper
• Clinical features and management of primary biliary cirrhosis.

  2008cites this paper
• Autoimmune liver disease

  2007cites this paper
• [Therapeutical targets for revert liver fibrosis].

  2007cites this paper
• Blancos terapéuticos potenciales para revertir la cirrosis hepática

  2007cites this paper
• Colchicine treatment of liver fibrosis.

  2006cites this paper
• Tratamiento de la enfermedad hepática crónica inducida por el virus de la hepatitis C: bases moleculares y celulares.

  2006cites this paper
• Colchicine for Primary Biliary Cirrhosis: A Cochrane Hepato-biliary Group Systematic Review of Randomized Clinical Trials

  2005cites this paper
• [Primary biliary liver cirrhosis and overlap syndrome. Diagnosis and therapy].

  2004cites this paper
• Colchicine for primary biliary cirrhosis.

  2004cites this paper
• Primär biliäre Leberzirrhose und Overlap-Syndrome

  2004cites this paper
• Oxidant stress is a significant feature of primary biliary cirrhosis.

  2003cites this paper
• Current management of primary biliary cirrhosis and primary sclerosing cholangitis.

  2003cites this paper
• Bezafibrate treatment: a new medical approach for PBC patients?

  2003cites this paper
• Primary biliary cirrhosis: specific treatment.

  2003cites this paper
• Lack of effect of colchicine in alcoholic cirrhosis: final results of a double blind randomized trial

  2002cites this paper
• Ursodeoxycholic acid for primary biliary cirrhosis.

  2002cites this paper
• Antifibrotic properties of botanicals in chronic liver disease.

  2002cites this paper
• Ten‐year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double‐blind, placebo‐controlled trial on symptomatic patients

  2001cites this paper
• Chronic liver injury, TGF-beta, and cancer.

  2001cites this paper
• Hepatic fibrosis. Pathogenesis and principles of therapy.

  2001cites this paper
• Drug therapy of primary biliary diseases: classical and modern strategies

  2001cites this paper
• Complications of urgent and emergency endoscopy in patients with GI bleeding as a function of time

  2001cites this paper
• Preliminary results of a two-center trial with colchicine for the treatment of chronic Hepatitis B

  2001cites this paper
• Medical Treatment of Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis

  2001cites this paper
• Chronic liver injury, TGF-β, and cancer

  2001cites this paper
• The history of liver disease at The Mount Sinai Hospital.

  2000cites this paper
• Update on primary biliary cirrhosis.

  2000cites this paper
• Primary biliary cirrhosis: new perspectives in diagnosis and treatment

  2000cites this paper
• Multicentre randomized placebo‐controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosis

  2000cites this paper
• Unfavourable effects of colchicine in combination with interferon‐α in the treatment of chronic hepatitis C

  2000cites this paper
• Treatment of primary biliary cirrhosis.

  2000cites this paper
• Cholestasis-induced fibrosis is reduced by interferon alpha-2a and is associated with elevated liver metalloprotease activity.

  2000cites this paper
• Evidence-based therapy of primary biliary cirrhosis.

  1999cites this paper
• The role of colchicine in prevention of hepatic cirrhosis induced by carbon tetrachloride.

  1999cites this paper
• Liver fibrogenesis and the role of hepatic stellate cells: New insights and prospects for therapy

  1999cites this paper
• A prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis.

  1999cites this paper
• Primary biliary cirrhosis and primary sclerosing cholangitis.

  1999cites this paper
• Cost‐effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis

  1999cites this paper
• Management of patients with primary biliary cirrhosis: a practical guide.

  1999cites this paper
• Management of Patients with Primary Biliary Cirrhosis

  1999cites this paper
• Methotrexate in the treatment of primary biliary cirrhosis: the hype and the hope.

  1999cites this paper
• Treatment of symptomatic primary biliary cirrhosis with lymphocytapheresis : a preliminary clinical trial

  1998cites this paper
• Colchicine in chronic hepatitis B: a pilot study

  1998cites this paper
• Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?

  1998cites this paper
• New clinical trials in primary biliary cirrhosis: design and endpoints

  1998cites this paper
• Methotrexate and colchicine in the treatment of primary biliary cirrhosis

  1998cites this paper
• Primary biliary cirrhosis

  1998cites this paper
• The scarring processes in mucosal tissues after immune injury.

  1998cites this paper
• Management of primary biliary cirrhosis and autoimmune cholangitis.

  1998cites this paper
• The Use of Methotrexate, Colchicine, and Other Immunomodulatory Drugs in the Treatment of Primary Biliary Cirrhosis

  1997cites this paper
• Trimethylcolchicinic Acid Decreases Liver Fibrosis and Cholestasis Induced by Prolonged Biliary Obstruction in the Rat

  1997cites this paper
• Primary Biliary Cirrhosis

  1996cites this paper
• Ursodeoxycholic acid treatment lowers the serum level of antibodies against pyruvate dehydrogenase and influences their inhibitory capacity for the enzyme complex in patients with primary biliary cirrhosis

  1996cites this paper
• Immunopathology of primary biliary cirrhosis.

  1996cites this paper
• Time course of histological progression in primary biliary cirrhosis

  1996cites this paper
• Colchicine reduces hepatic fibrosis in mice infected with Schistosoma japonicum.

  1996cites this paper
• Effect of colchicine and trimethylcolchicinic acid on CCl4-induced cirrhosis in the rat.

  1996cites this paper
• A prospective randomized trial of colchicine in prevention of liver cirrhosis in chronic hepatitis B patients

  1996cites this paper
• Primary biliary cirrhosis.

  1996cites this paper
• Primary biliary cirrhosis clinical research single‐topic conference

  1996cites this paper
• Diagnosis and therapy of cholestatic liver disease.

  1996cites this paper
• A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group.

  1996cites this paper
• Pharmacological Treatment of Primary Biliary Cirrhosis

  1996cites this paper
• A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis

  1996cites this paper
• 5 Immunopathology of primary biliary cirrhosis

  1996cites this paper
• Effects of additional administration of colchicine in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: a prospective randomized study.

  1996cites this paper
• [Colchicine].

  1996cites this paper
• Synthesis of interleukin‐1β in primary biliary cirrhosis: Relationship to treatment with methotrexate or colchicine and disease progression

  1995cites this paper
• Bile acid and immunosuppressive therapy in primary biliary cirrhosis

  1995cites this paper
• A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid.

  1995cites this paper
• Colchicine and ursodeoxycholic acid for primary biliary cirrhosis: emerging results.

  1995cites this paper
• Serum cholestanol, cholesterol precursors, and plant sterols during placebo‐controlled treatment of primary biliary cirrhosis with ursodeoxycholic acid or colchicine

  1995cites this paper
• Colchicine induces enhanced intestinal permeability in the rat.

  1995cites this paper
• Interferon-alpha 2b increases fibrolysis in fibrotic livers from bile duct ligated rats: possible participation of the plasminogen activator.

  1995cites this paper
• Perspectives in the treatment of liver fibrosis.

  1995cites this paper
• Ursodeoxycholic acid therapy of chronic cholestatic conditions in adults and children.

  1995cites this paper
• Characterisation of patients with a complete biochemical response to ursodeoxycholic acid.

  1995cites this paper
• Colchicine treatment of primary sclerosing cholangitis.

  1995cites this paper
• [Bile acids in therapy of liver diseases].

  1994cites this paper
• Plasma kinetics and biliary excretion of colchicine in patients with chronic liver disease after oral administration of a single dose and after long-term treatment.

  1994cites this paper